ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/19 | 2,259 | 2,259 | 2,202 | 2,212 | -38 | -1.7% | 75,400 |
2023/04/18 | 2,228 | 2,262 | 2,226 | 2,250 | +16 | +0.7% | 25,200 |
2023/04/17 | 2,255 | 2,260 | 2,218 | 2,234 | -26 | -1.2% | 65,100 |
2023/04/14 | 2,261 | 2,272 | 2,243 | 2,260 | +8 | +0.4% | 32,500 |
2023/04/13 | 2,261 | 2,266 | 2,236 | 2,252 | -14 | -0.6% | 46,200 |
2023/04/12 | 2,257 | 2,280 | 2,246 | 2,266 | +12 | +0.5% | 34,900 |
2023/04/11 | 2,257 | 2,281 | 2,245 | 2,254 | +10 | +0.4% | 30,000 |
2023/04/10 | 2,254 | 2,272 | 2,239 | 2,244 | +5 | +0.2% | 27,600 |
2023/04/07 | 2,261 | 2,267 | 2,224 | 2,239 | -22 | -1% | 49,800 |
2023/04/06 | 2,287 | 2,295 | 2,260 | 2,261 | -23 | -1% | 34,500 |
2023/04/05 | 2,334 | 2,342 | 2,278 | 2,284 | -50 | -2.1% | 58,600 |
2023/04/04 | 2,350 | 2,359 | 2,322 | 2,334 | -22 | -0.9% | 42,700 |
2023/04/03 | 2,344 | 2,380 | 2,331 | 2,356 | +25 | +1.1% | 51,100 |
2023/03/31 | 2,309 | 2,335 | 2,309 | 2,331 | +18 | +0.8% | 24,500 |
2023/03/30 | 2,302 | 2,332 | 2,288 | 2,313 | +5 | +0.2% | 31,600 |
2023/03/29 | 2,286 | 2,320 | 2,274 | 2,308 | +14 | +0.6% | 22,800 |
2023/03/28 | 2,317 | 2,317 | 2,274 | 2,294 | -5 | -0.2% | 43,200 |
2023/03/27 | 2,296 | 2,322 | 2,279 | 2,299 | +7 | +0.3% | 52,000 |
2023/03/24 | 2,291 | 2,292 | 2,260 | 2,292 | -14 | -0.6% | 40,700 |
2023/03/23 | 2,319 | 2,320 | 2,269 | 2,306 | -8 | -0.3% | 38,100 |
2023/03/22 | 2,348 | 2,362 | 2,309 | 2,314 | +15 | +0.7% | 48,400 |
2023/03/20 | 2,382 | 2,383 | 2,290 | 2,299 | -83 | -3.5% | 92,500 |
2023/03/17 | 2,384 | 2,412 | 2,382 | 2,382 | +10 | +0.4% | 28,100 |
2023/03/16 | 2,370 | 2,395 | 2,355 | 2,372 | -35 | -1.5% | 52,800 |
2023/03/15 | 2,419 | 2,446 | 2,400 | 2,407 | +34 | +1.4% | 49,800 |
2023/03/14 | 2,400 | 2,460 | 2,373 | 2,373 | -60 | -2.5% | 107,700 |
2023/03/13 | 2,455 | 2,465 | 2,410 | 2,433 | -52 | -2.1% | 79,700 |
2023/03/10 | 2,533 | 2,535 | 2,465 | 2,485 | -54 | -2.1% | 91,200 |
2023/03/09 | 2,500 | 2,539 | 2,493 | 2,539 | +53 | +2.1% | 63,600 |
2023/03/08 | 2,488 | 2,515 | 2,486 | 2,486 | -9 | -0.4% | 48,300 |
2023/03/07 | 2,495 | 2,510 | 2,487 | 2,495 | ±0 | ±0% | 39,900 |
2023/03/06 | 2,480 | 2,515 | 2,476 | 2,495 | +20 | +0.8% | 63,900 |
2023/03/03 | 2,470 | 2,483 | 2,449 | 2,475 | +23 | +0.9% | 44,400 |
2023/03/02 | 2,446 | 2,473 | 2,438 | 2,452 | -19 | -0.8% | 71,900 |
2023/03/01 | 2,502 | 2,516 | 2,458 | 2,471 | -31 | -1.2% | 56,800 |
2023/02/28 | 2,502 | 2,519 | 2,477 | 2,502 | +32 | +1.3% | 67,800 |
2023/02/27 | 2,445 | 2,482 | 2,430 | 2,470 | +20 | +0.8% | 54,200 |
2023/02/24 | 2,470 | 2,470 | 2,416 | 2,450 | -47 | -1.9% | 119,800 |
2023/02/22 | 2,520 | 2,536 | 2,474 | 2,497 | -52 | -2% | 101,800 |
2023/02/21 | 2,560 | 2,612 | 2,541 | 2,549 | -21 | -0.8% | 88,400 |
2023/02/20 | 2,586 | 2,608 | 2,559 | 2,570 | -14 | -0.5% | 70,300 |
2023/02/17 | 2,618 | 2,633 | 2,569 | 2,584 | -56 | -2.1% | 94,200 |
2023/02/16 | 2,638 | 2,668 | 2,625 | 2,640 | -8 | -0.3% | 89,900 |
2023/02/15 | 2,709 | 2,758 | 2,646 | 2,648 | -62 | -2.3% | 144,600 |
2023/02/14 | 2,788 | 2,793 | 2,651 | 2,710 | -50 | -1.8% | 189,900 |
2023/02/13 | 2,768 | 2,874 | 2,745 | 2,760 | +21 | +0.8% | 207,000 |
2023/02/10 | 3,150 | 3,215 | 2,675 | 2,739 | -411 | -13% | 583,600 |
2023/02/09 | 3,145 | 3,200 | 3,115 | 3,150 | ±0 | ±0% | 115,500 |
2023/02/08 | 3,155 | 3,165 | 3,115 | 3,150 | -5 | -0.2% | 51,500 |
2023/02/07 | 3,185 | 3,190 | 3,135 | 3,155 | -30 | -0.9% | 50,500 |
401~
450
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 155,700円 | -5.1% | -21.2% | 5.14% | 9.83倍 | 1.88倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ハートシード | 148,500円 | +154.1% | - | 0.00% | - | 7.27倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ダイト | 212,700円 | +4.5% | -10.8% | 3.29% | 14.15倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
扶桑薬 | 253,600円 | +8.3% | +98.1% | 3.23% | 8.33倍 | 0.58倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
セルソース | 102,700円 | -3.0% | -55.9% | 0.49% | 48.79倍 | 3.37倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム